Science Explorer Interactive view Map
Research facility · Strasbourg · France

Institute for Translational Medicine and Liver Disease

liverstrasbourg.orgROR OpenAlex
Research works
27
▲ 23% vs 2013–17
Citations
1.5k
57.2 per fractional work
Top-10% rate
23.1%
record average 16.5%
Open access
70%
world 28%

Not ranked overall: Institute for Translational Medicine and Liver Disease is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.08× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.55× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.73× its world share, 0 worksImmunology and Micro…Neuroscience: 2.97× its world share, 0 worksNeuroscienceComputer Science: 0.22× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.30× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.21× its world share, 0 worksHealth ProfessionsMedicine: 3.87× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.

Which keywords describe research at Institute for Translational Medicine and Liver Disease?

By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Antiviral Therapy, Liver Disease, Hepatocellular Carcinoma, Treatment, Epidemiology, Hepatitis C Virus and Ribavirin.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Immune Response8▲ 48×9 topics
  2. Antiviral Therapy7▲ 180×2 topics
  3. Liver Disease7▲ 198×2 topics
  4. Hepatocellular Carcinoma7▲ 118×3 topics
  5. Epidemiology6▲ 5.4×16 topics
  6. Treatment5▲ 15×3 topics
  7. Hepatitis C Virus4▲ 292×1 topic
  8. Ribavirin4▲ 292×1 topic
  9. Global Burden4▲ 24×3 topics
  10. Chronic Hepatitis B3▲ 228×1 topic
  11. Hepatitis B Virus3▲ 228×1 topic
  12. Metabolic Syndrome3▲ 13×3 topics
  13. Insulin Resistance3▲ 23×3 topics
  14. NAFLD3▲ 94×1 topic
  15. NASH3▲ 94×1 topic
  16. Cancer2▲ 5.8×20 topics
  17. Inflammation1▲ 2.3×21 topics
  18. Diagnosis1▲ 4.7×4 topics
  19. Management1▲ 5.7×3 topics
  20. Mortality1▲ 8.0×2 topics
  21. Clinical Practice Guidelines1▲ 6.8×5 topics
  22. Oxidative Stress1▲ 2.1×12 topics
  23. Survival1▲ 29×2 topics
  24. Tumor Microenvironment1▲ 11×6 topics

Which research topics does Institute for Translational Medicine and Liver Disease publish most on?

By volume in 2022–2025: Hepatitis B Virus Studies, Hepatitis C virus research, Chronic Obstructive Pulmonary Disease (COPD) Research and Cholangiocarcinoma and Gallbladder Cancer Studies.

Hepatitis B Virus Studies1Hepatitis B Virus Studies: 1 fractional worksHepatitis C virus research: 0 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 0 fractional worksCholangiocarcinoma and Gallbladder Cancer Studies: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksPancreatic and Hepatic O…0Pancreatic and Hepatic Oncology Research: 0 fractional worksCancer Risks and Factors: 0 fractional worksGallbladder and Bile Duct Disorders: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
EpidemiologyHepatologyPulmonary and Respiratory MedicineSurgery1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hepatitis B Virus Studies Epidemiology 1 works
  2. 2 Hepatitis C virus research Hepatology 0 works
  3. 3 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  4. 4 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
  5. 5 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  6. 6 Pancreatic and Hepatic Oncology Research Oncology 0 works
  7. 7 Cancer Risks and Factors Oncology 0 works
  8. 8 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works
  9. 9 Peptidase Inhibition and Analysis Oncology 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available69.7%not open30.3%

World: 28% of research is openly available.

with international co-authors43.1%domestic only56.9%

World: 19% is written across borders.

How has Institute for Translational Medicine and Liver Disease's research output changed?

Output in 2018–2022 was 23% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Strasbourg

All research institutions in Strasbourg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.